1035351-06-4

Basic information

• Product Name: 1-{[(1,1-diMethylethyl)oxy]carbonyl}-3-hydroxyazetidine-3-carboxylic acid
• Synonyms: 1-{[(1,1-diMethylethyl)oxy]carbonyl}-3-hydroxyazetidine-3-carboxylic acid;1-[(tert-butoxy)carbonyl]-3-hydroxyazetidine-3-carboxylic acid
• CAS NO: 1035351-06-4
• Molecular Formula: C₉H₁₅NO₅
• Molecular Weight: 217.2191
• EINECS: -0
• Mol File: 1035351-06-4.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 371.3±42.0 °C(Predicted)
• Appearance: /
• Density: 1.384±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.57±0.20(Predicted)
• CAS DataBase Reference: 1-{[(1,1-diMethylethyl)oxy]carbonyl}-3-hydroxyazetidine-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-{[(1,1-diMethylethyl)oxy]carbonyl}-3-hydroxyazetidine-3-carboxylic acid(1035351-06-4)
• EPA Substance Registry System: 1-{[(1,1-diMethylethyl)oxy]carbonyl}-3-hydroxyazetidine-3-carboxylic acid(1035351-06-4)

Safety Data

• Hazardous Substances Data: 1035351-06-4(Hazardous Substances Data)

Usage

General Description

"1-{[(1,1-diMethylethyl)oxy]carbonyl}-3-hydroxyazetidine-3-carboxylic acid" is a chemical compound known for its complex structure. This organic chemical belongs to the group of azetidines, which are saturated heterocyclic compounds containing a three-membered ring system with three carbon atoms and one nitrogen atom. This particular compound is characterized by an azetidine ring substructure linked with a carboxylic acid group and a hydroxy group. It also features a tert-butyl group bound through an oxygen atom. Though its specific uses and properties may vary, substances with similar structures are often involved in pharmaceuticals and organic synthesis.

Upstream product

• 398489-26-4 tert-butyl 3-oxoazetidine-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 70807-37-3 3-hydroxyazetidine-3-carboxylic acid 
• 1493737-08-8 C₉H₁₄N₂O₃ 
• 70767-62-3 3-hydroxyazetidine-3-carboxylic acid hydrochloride 

Downstream Products

• 1286171-94-5 C₇₁H₈₅N₉O₂₄ 
• 1346507-95-6 tert-butyl 3-((1R,2S,3S,4R,5S)-4-((2R,3R,6S)-6-((tert-butoxycarbonyl(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)amino)methyl)-3-(tert-butoxycarbonylamino)tetrahydro-2H-pyran-2-yloxy)-2-((2R,3R,4R,5R)-4-(tert-butoxycarbonyl(methyl)amino)-3,5-dihydroxy-5-methyltetrahydro-2H-pyran-2-yloxy)-5-(tert-butoxycarbonylamino)-3-hydroxycyclohexylcarbamoyl)-3-hydroxyazetidine-1-carboxylate 
• 1287277-28-4 C₈₆H₉₇N₇O₂₇ 

Relevant articles and documents

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

Compounds and compositions useful for treating disorders related to Kit are described herein.

COFERONS AND METHODS OF MAKING AND USING THEM

The present invention is directed to a monomer useful in preparing therapeutic compounds. The monomer includes one or more pharmacophores which potentially binds to a target molecule with a dissociation constant of less than 300 μM and a linker element connected to the pharmacophore. The linker element has a molecular weight less than 500 daltons, is connected, directly or indirectly through a connector, to the pharmacophore.

ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): (Formula (I)), including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2, R3, Z1 and Z2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.